Atara Biotherapeutics, Inc.·4

Mar 27, 5:17 PM ET

Porter Derrell 4

4 · Atara Biotherapeutics, Inc. · Filed Mar 27, 2019

Insider Transaction Report

Form 4
Period: 2019-03-26
Porter Derrell
SVP, Head of Global Commercial
Transactions
  • Award

    Common Stock

    2019-03-26+10,00031,688 total
Footnotes (1)
  • [F1]These restricted stock units vest as to 50% of the shares on March 26, 2020 and 50% of the shares on March 26, 2021, subject to the reporting person's continuous service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION